Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study
Michael Marberger, Stephen J. Freedland, Gerald L. Andriole, Mark Emberton, Curtis Pettaway, Francesco Montorsi, Claudio Teloken, Roger S. Rittmaster, Matthew C. Somerville, Ramiro Castro
Dive into the research topics of 'Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study'. Together they form a unique fingerprint.